Sotac Pharmaceuticals Limited (NSE:SOTAC)
111.00
0.00 (0.00%)
May 27, 2026, 10:32 AM IST
Sotac Pharmaceuticals Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 11.78 | 15.64 | 34.18 | 96.82 | 0.28 |
Short-Term Investments | - | 4.59 | 4.33 | 4.12 | - |
Cash & Short-Term Investments | 11.78 | 20.23 | 38.51 | 100.94 | 0.28 |
Cash Growth | -41.77% | -47.47% | -61.85% | 36470.65% | -93.68% |
Accounts Receivable | 329.5 | 341.12 | 262.88 | 147.41 | 122.53 |
Other Receivables | - | 0.02 | - | 3.22 | 0.55 |
Receivables | 332.87 | 341.14 | 262.88 | 150.63 | 123.08 |
Inventory | 270.77 | 202.61 | 180.1 | 136.42 | 53.95 |
Prepaid Expenses | - | 2.15 | 1.39 | 0.55 | 0.11 |
Other Current Assets | 161.37 | 132.14 | 123.58 | 82.85 | 81.35 |
Total Current Assets | 776.79 | 698.27 | 606.45 | 471.39 | 258.76 |
Property, Plant & Equipment | 474.81 | 469.71 | 387.19 | 240.5 | 87.94 |
Long-Term Investments | 29.16 | 37.82 | 20.96 | - | 3.92 |
Goodwill | 19.03 | 19.03 | 19.01 | 19.06 | - |
Other Intangible Assets | 19.87 | 0.19 | 0.13 | 0.03 | 0.05 |
Long-Term Deferred Tax Assets | 9.78 | 13.01 | 14.27 | - | 0.2 |
Other Long-Term Assets | - | 5.25 | 5.25 | 5.25 | 1.66 |
Total Assets | 1,335 | 1,243 | 1,053 | 736.39 | 352.54 |
Accounts Payable | 271.92 | 189.44 | 288.94 | 253.94 | 197.42 |
Accrued Expenses | - | 8.2 | 6.5 | 9.63 | 4.42 |
Short-Term Debt | 272.09 | 187.51 | 98.75 | 108.24 | 51.86 |
Current Portion of Long-Term Debt | - | 107.54 | 28.53 | 34.46 | 12.31 |
Current Income Taxes Payable | - | 9.14 | 3.97 | 15.95 | - |
Other Current Liabilities | 39.59 | 13.65 | 10.61 | 35.91 | 10.05 |
Total Current Liabilities | 583.6 | 515.49 | 437.3 | 458.12 | 276.05 |
Long-Term Debt | 103.88 | 141.94 | 121.31 | 77.69 | 9.7 |
Pension & Post-Retirement Benefits | 1.51 | 1.63 | 1.37 | 0.96 | 0.56 |
Long-Term Deferred Tax Liabilities | - | - | - | 2.77 | - |
Total Liabilities | 688.99 | 659.06 | 559.98 | 539.54 | 286.32 |
Common Stock | 110.5 | 110.5 | 110.5 | 80.5 | 23 |
Additional Paid-In Capital | - | 280.23 | 280.22 | - | - |
Retained Earnings | - | 139.07 | 58.81 | 16 | - |
Comprehensive Income & Other | 478.25 | 2.73 | 3.06 | 98.1 | 43.22 |
Total Common Equity | 588.75 | 532.52 | 452.59 | 194.59 | 66.22 |
Minority Interest | 56.97 | 51.7 | 40.7 | 2.26 | - |
Shareholders' Equity | 645.72 | 584.22 | 493.29 | 196.86 | 66.22 |
Total Liabilities & Equity | 1,335 | 1,243 | 1,053 | 736.39 | 352.54 |
Total Debt | 375.97 | 436.99 | 248.59 | 220.39 | 73.88 |
Net Cash (Debt) | -364.19 | -416.76 | -210.08 | -119.45 | -73.6 |
Net Cash Per Share | -32.97 | -37.72 | -19.14 | -14.84 | -9.14 |
Filing Date Shares Outstanding | 11.03 | 11.05 | 11.05 | 8.05 | 8.05 |
Total Common Shares Outstanding | 11.03 | 11.05 | 11.05 | 8.05 | 8.05 |
Working Capital | 193.2 | 182.78 | 169.15 | 13.27 | -17.29 |
Book Value Per Share | 53.39 | 48.19 | 40.96 | 24.17 | 8.23 |
Tangible Book Value | 549.84 | 513.3 | 433.45 | 175.5 | 66.17 |
Tangible Book Value Per Share | 49.86 | 46.45 | 39.23 | 21.80 | 8.22 |
Land | - | 87.41 | 87.41 | 39.22 | 11.92 |
Buildings | - | 165.42 | 89.61 | 82.7 | 30.2 |
Machinery | - | 353.72 | 259.72 | 188.01 | 93.24 |
Construction In Progress | - | 2.04 | 51.24 | 0.41 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.